Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)

BACKGROUND: Non–vitamin K antagonist oral anticoagulants (NOACs) are indicated for stroke prevention in atrial fibrillation (AF) but require lower doses in certain patients. We sought to describe the frequency, appropriateness (according to Food and Drug Administration labeling), and outcomes of pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Am Heart Assoc
Hauptverfasser: Steinberg, Benjamin A., Shrader, Peter, Pieper, Karen, Thomas, Laine, Allen, Larry A., Ansell, Jack, Chan, Paul S., Ezekowitz, Michael D., Fonarow, Gregg C., Freeman, James V., Gersh, Bernard J., Kowey, Peter R., Mahaffey, Kenneth W., Naccarelli, Gerald V., Reiffel, James A., Singer, Daniel E., Peterson, Eric D., Piccini, Jonathan P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2018
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850192/
https://ncbi.nlm.nih.gov/pubmed/29453305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007633
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge